Skip to content

The ovario-protective effect of erythropoeitin against oxidative damage associated with reperfusion following ovarian torsion

The ovario-protective effect of erythropoeitin against oxidative damage associated with reperfusion following ovarian torsion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011305283N1
Enrollment
40
Registered
2011-05-05
Start date
2009-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian torsion. Torsion of ovary, ovarian pedicle and fallopian tube

Interventions

Intervention 1: For the intervention group erythropoietin, 150 IU/kg will be injected during surgery and 48 hours after surgery. Intervention 2: Routine surgery in the control group.
Treatment - Drugs
Treatment - Surgery
For the intervention group erythropoietin, 150 IU/kg will be injected during surgery and 48 hours after surgery
Routine surgery in the control group

Sponsors

Tabriz University of Medical Sciences and Health Services
Lead Sponsor
Women's Reproductive Health Research Center
Collaborator

Eligibility

Sex/Gender
Female
Age
17 Years to 44 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with clinical symptoms and findings of sonography in favor of ovarian torsion Excluding criteria: hypertension, bleeding, thrombotic complications background, pregnancy, or dissatisfaction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Color dopller finding. Timepoint: before surgery and 24 h after surgery. Method of measurement: color dopller finding and ovarian torsion.

Secondary

MeasureTime frame
GSH. Timepoint: Befor Surgery and 24 h after surgery. Method of measurement: Para clinical.;NO. Timepoint: Before Surgery and 24 h after surgery. Method of measurement: Para clinical.;SOD. Timepoint: Before Surgery and 24 h after surgery. Method of measurement: Para clinical.;XO. Timepoint: Before Surgery and 24 h after surgery. Method of measurement: Para clinical.;MDA. Timepoint: Before Surgery and 24 h after surgery. Method of measurement: Para clinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactManizheh Sayyah Melli

Tabriz University of Medical Sciences and Health Services

manizheh.sayyahmelli@gmail.com+98 914 115 8085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026